Now you see me, now you don't: the interaction of Salmonella with innate immune receptors

Nature Reviews Microbiology

Volumn 13, Issue 4, 2015, Pages 206-216

  Keestra Gounder, A Marijke ^a   Tsolis, Renée M ^a   Bäumler, Andreas J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRULENCE FACTOR; IMMUNOGLOBULIN RECEPTOR;

BACTEREMIA; BACTERIUM DETECTION; COMPLEMENT SYSTEM; GASTROENTERITIS; GENE CONTROL; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE EVASION; IMMUNOCOMPROMISED PATIENT; INNATE IMMUNITY; NON TYPHOIDAL SALMONELLA; NONHUMAN; PRIORITY JOURNAL; REVIEW; SALMONELLA; SALMONELLA ENTERICA SUBSP. ENTERICA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; TYPHOID FEVER; ANIMAL; CLASSIFICATION; GENETICS; IMMUNOLOGY; MICROBIOLOGY; PHYSIOLOGY; SALMONELLA ENTERICA; SALMONELLA ENTERICA SEROVAR TYPHI;

BACTERIA (MICROORGANISMS); SALMONELLA; SALMONELLA ENTERICA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; SALMONELLA TYPHI;

ANIMALS; HUMANS; IMMUNITY, INNATE; RECEPTORS, IMMUNOLOGIC; SALMONELLA ENTERICA; SALMONELLA TYPHI; TYPHOID FEVER; VIRULENCE FACTORS;

EID: 84925088944     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro3428     Document Type: Review

References (143)

1. Tsolis, R. M., Xavier, M. N., Santos, R. L. & Bäumler, A. J. How to become a top model: impact of animal experimentation on human Salmonella disease research. Infect. Immun. 79, 1806-1814 (2011
2. Khan, S. A. et al. A lethal role for lipid A in Salmonella infections. Mol. Microbiol. 29, 571-579 (1998
3. Zhang, S. et al. Molecular pathogenesis of Salmonella enterica serotype Typhimurium-induced diarrhea. Infect. Immun. 71, 1-12 (2003
4. Rabsch, W., Tschape, H. & Bäumler, A. J. Non-typhoidal salmonellosis: emerging problems. Microbes Infect. 3, 237-247 (2001
5. Reddy, E. A., Shaw, A. V. & Crump, J. A. Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect. Dis. 10, 417-432 (2010
6. Feasey, N. A., Dougan, G., Kingsley, R. A., Heyderman, R. S. & Gordon, M. A. Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa. Lancet 379, 2489-2499 (2012
7. Gordon, M. A. et al. Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence. AIDS 16, 1633-1641 (2002
8. De Wit, S., Taelman, H., Van de Perre, P., Rouvroy, D. & Clumeck, N. Salmonella bacteremia in African patients with human immunodeficiency virus infection. Eur. J. Clin. Microbiol. Infect. Dis. 7, 45-47 (1988
9. Brown, D. E., McCoy, M. W., Pilonieta, M. C., Nix, R. N. & Detweiler, C. S. Chronic murine typhoid fever is a natural model of secondary hemophagocytic lymphohistiocytosis. PloS ONE 5, e9441 (2010
10. OBrien, A. D., Rosenstreich, D. L. & Taylor, B. A. Control of natural resistance to Salmonella typhimurium and Leishmania donovani in mice by closely linked but distinct genetic loci. Nature 287, 440-442 (1980
11. Poltorak, A. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085-2088 (1998
12. Arpaia, N. et al. TLR signaling is required for Salmonella typhimurium virulence. Cell 144, 675-688 (2011
13. Lai, M. A. et al. Innate immune detection of flagellin positively and negatively regulates salmonella infection. PLoS ONE 8, e72047 (2013
14. Cummings, L. A., Wilkerson, W. D., Bergsbaken, T. & Cookson, B. T. In vivo, fliC expression by Salmonella enterica serovar Typhimurium is heterogeneous, regulated by ClpX, and anatomically restricted. Mol. Microbiol. 61, 795-809 (2006
15. Bernheiden, M. et al. LBP, CD14, TLR4 and the murine innate immune response to a peritoneal Salmonella infection. J. Endotoxin Res. 7, 447-450 (2001
16. Vazquez-Torres, A. et al. Toll-like receptor 4 dependence of innate and adaptive immunity to Salmonella: importance of the Kupffer cell network. J. Immunol. 172, 6202-6208 (2004
17. Weiss, D. S., Raupach, B., Takeda, K., Akira, S. & Zychlinsky, A. Toll-like receptors are temporally involved in host defense. J. Immunol. 172, 4463-4469 (2004
18. Talbot, S. et al. Toll-like receptor 4 signalling through MyD88 is essential to control Salmonella enterica serovar Typhimurium infection, but not for the initiation of bacterial clearance. Immunology 128, 472-483 (2009
19. Joiner, K. A., Hammer, C. H., Brown, E. J. & Frank, M. M. Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane. J. Exp. Med. 155, 809-819 (1982
20. Murray, G. L., Attridge, S. R. & Morona, R. Regulation of Salmonella typhimurium lipopolysaccharide O antigen chain length is required for virulence; identification of FepE as a second Wzz. Mol. Microbiol. 47, 1395-1406 (2003
21. Holzer, S. U., Schlumberger, M. C., Jackel, D. & Hensel, M. Effect of the O antigen length of lipopolysaccharide on the functions of type III secretion systems in Salmonella enterica. Infect. Immun. 77, 5458-5470 (2009
22. Wangdi, T. et al. The Vi capsular polysaccharide enables Salmonella enterica serovar Typhi to evade microbe-guided neutrophil chemotaxis. PLoS Pathog. 10, e1004306 (2014
23. Smedegard, G., Cui, L. X. & Hugli, T. E. Endotoxin-induced shock in the rat. A role for C5a. Am. J. Pathol. 135, 489-497 (1989
24. Riedemann, N. C. et al. Expression and function of the C5a receptor in rat alveolar epithelial cells. J. Immunol. 168, 1919-1925 (2002
25. Montz, H., Koch, K. C., Zierz, R. & Gotze, O. The role of C5a in interleukin 6 production induced by lipopolysaccharide or interleukin 1. Immunology 74, 373-379 (1991
26. Vidal, S. M., Malo, D., Vogan, K., Skamene, E. & Gros, P. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 73, 469-485 (1993
27. Seok, J. et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl Acad. Sci. USA 110, 3507-3512 (2013
28. Broz, P. et al. Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella. J. Exp. Med. 207, 1745-1755 (2010
29. Man, S. M. et al. Inflammasome activation causes dual recruitment of NLRC4 and NLRP3 to the same macromolecular complex. Proc. Natl Acad. Sci. USA 111, 7403-7408 (2014
30. Franchi, L. et al. Cytosolic flagellin requires Ipaf for activation of caspase 1 and interleukin 1β in salmonella-infected macrophages. Nature Immunol. 7, 576-582 (2006
31. Miao, E. A. et al. Cytoplasmic flagellin activates caspase 1 and secretion of interleukin 1β via Ipaf. Nature Immunol. 7, 569-575 (2006
32. Sun, Y. H., Rolan, H. G. & Tsolis, R. M. Injection of flagellin into the host cell cytosol by Salmonella enterica serotype Typhimurium. J. Biol. Chem. 282, 33897-33901 (2007
33. Miao, E. A. et al. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc. Natl Acad. Sci. USA 107, 3076-3080 (2010
34. Yang, J., Zhao, Y., Shi, J. & Shao, F. Human NAIP and mouse NAIP1 recognize bacterial type III secretion needle protein for inflammasome activation. Proc. Natl Acad. Sci. USA 110, 14408-14413 (2013
35. Rayamajhi, M., Zak, D. E., Chavarria-Smith, J., Vance, R. E. & Miao, E. A. Cutting edge: mouse NAIP1 detects the type III secretion system needle protein. J. Immunol. 191, 3986-3989 (2013
36. Kofoed, E. M. & Vance, R. E. Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity. Nature 477, 592-595 (2011
37. Zhao, Y. et al. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 477, 596-600 (2011
38. Sander, L. E. et al. Detection of prokaryotic mRNA signifies microbial viability and promotes immunity. Nature 474, 385-389 (2011
39. Rathinam, V. A. et al. TRIF licenses caspase 11 dependent NLRP3 inflammasome activation by Gram-negative bacteria. Cell 150, 606-619 (2012
40. Meunier, E. et al. Caspase 11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases. Nature 509, 366-370 (2014
41. Pilla, D. M. et al. Guanylate binding proteins promote caspase 11 dependent pyroptosis in response to cytoplasmic LPS. Proc. Natl Acad. Sci. USA 111, 6046-6051 (2014
42. Hagar, J. A., Powell, D. A., Aachoui, Y., Ernst, R. K. & Miao, E. A. Cytoplasmic LPS activates caspase 11: implications in TLR4 independent endotoxic shock. Science 341, 1250-1253 (2013
43. Kayagaki, N. et al. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 341, 1246-1249 (2013
44. Broz, P. et al. Caspase 11 increases susceptibility to Salmonella infection in the absence of caspase 1. Nature 490, 288-291 (2012
45. Shi, J. et al. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature 514, 187-192 (2014
46. Miao, E. A. et al. Caspase 1 induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nature Immunol. 11, 1136-1142 (2010
47. Tsolis, R. M. et al. Of mice, calves, and men. Comparison of the mouse typhoid model with other Salmonella infections. Adv. Exp. Med. Biol. 473, 261-274 (1999
48. Barthel, M. et al. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect. Immun. 71, 2839-2858 (2003
49. Hapfelmeier, S. et al. Microbe sampling by mucosal dendritic cells is a discrete, MyD88 independent step in DeltainvG S. Typhimurium colitis. J. Exp. Med. 205, 437-450 (2008
50. Franchi, L. et al. NLRC4 driven production of IL 1β discriminates between pathogenic and commensal bacteria and promotes host intestinal defense. Nature Immunol. 13, 449-456 (2012
51. Smith, P. D. et al. Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J. Immunol. 167, 2651-2656 (2001
52. Cookson, B. T. & Bevan, M. J. Identification of a natural T cell epitope presented by Salmonella-infected macrophages and recognized by T cells from orally immunized mice. J. Immunol. 158, 4310-4319 (1997
53. McSorley, S. J., Cookson, B. T. & Jenkins, M. K. Characterization of CD4+ T cell responses during natural infection with Salmonella typhimurium. J. Immunol. 164, 986-993 (2000
54. Atif, S. M., Uematsu, S., Akira, S. & McSorley, S. J. CD103-CD11b+ dendritic cells regulate the sensitivity of CD4 T cell responses to bacterial flagellin. Mucosal Immunol. 7, 68-77 (2014
55. Tukel, C. et al. CsgA is a pathogen-associated molecular pattern of Salmonella enterica serotype Typhimurium that is recognized by Toll-like receptor 2. Mol. Microbiol. 58, 289-304 (2005
56. Nishimori, J. H. et al. Microbial amyloids induce interleukin 17A (IL 17A) and IL 22 responses via Toll-like receptor 2 activation in the intestinal mucosa. Infect. Immun. 80, 4398-4408 (2012
57. Tukel, C. et al. Responses to amyloids of microbial and host origin are mediated through Toll-like receptor 2. Cell Host Microbe 6, 45-53 (2009
58. Romling, U. et al. Occurrence and regulation of the multicellular morphotype in Salmonella serovars important in human disease. Int. J. Med. Microbiol. 293, 273-285 (2003
59. Tukel, C. et al. Toll-like receptors 1 and 2 cooperatively mediate immune responses to curli, a common amyloid from enterobacterial biofilms. Cell. Microbiol. 12, 1495-1505 (2010
60. Hapfelmeier, S. et al. The Salmonella pathogenicity island (SPI)-2 and SPI 1 type III secretion systems allow Salmonella serovar typhimurium to trigger colitis via MyD88 dependent and MyD88 independent mechanisms. J. Immunol. 174, 1675-1685 (2005
61. Keestra, A. M. et al. Early MyD88 dependent induction of interleukin 17A expression during Salmonella colitis. Infect. Immun. 79, 3131-3140 (2011
62. Muzio, M., Ni, J., Feng, P. & Dixit, V. M. IRAK (Pelle) family member IRAK 2 and MyD88 as proximal mediators of IL 1 signaling. Science 278, 1612-1615 (1997
63. Wesche, H., Henzel, W. J., Shillinglaw, W., Li, S. & Cao, Z. MyD88: an adapter that recruits IRAK to the IL 1 receptor complex. Immunity 7, 837-847 (1997
64. Awoniyi, M., Miller, S. I., Wilson, C. B., Hajjar, A. M. & Smith, K. D. Homeostatic regulation of Salmonella-induced mucosal inflammation and injury by IL 23. PloS ONE 7, e37311 (2012
65. Rhee, S. J., Walker, W. A. & Cherayil, B. J. Developmentally regulated intestinal expression of IFN-? and its target genes and the age-specific response to enteric Salmonella infection. J. Immunol. 175, 1127-1136 (2005
66. Müller, A. J. et al. The S. typhimurium effector SopE induces caspase 1 activation in stromal cells to initiate gut inflammation. Cell Host Microbe 6, 125-136 (2009
67. Knodler, L. A. et al. Dissemination of invasive Salmonella via bacterial-induced extrusion of mucosal epithelia. Proc. Natl Acad. Sci. USA 107, 17733-17738 (2010
68. Knodler, L. A. et al. Noncanonical inflammasome activation of caspase 4/caspase 11 mediates epithelial defenses against enteric bacterial pathogens. Cell Host Microbe 16, 249-256 (2014
69. Sellin, M. E. et al. Epithelium-intrinsic NAIP/NLRC4 inflammasome drives infected enterocyte expulsion to restrict Salmonella replication in the intestinal mucosa. Cell Host Microbe 16, 237-248 (2014
70. Laughlin, R. C. et al. Spatial segregation of virulence gene expression during acute enteric infection with Salmonella enterica serovar Typhimurium. mBio 5, e00946 13 (2014
71. Zhang, K. et al. Age-dependent enterocyte invasion and microcolony formation by Salmonella. PLoS Pathog. 10, e1004385 (2014
72. Winter, S. E. et al. Contribution of flagellin pattern recognition to intestinal inflammation during Salmonella enterica serotype Typhimurium infection. Infect. Immun. 77, 1904-1916 (2009
73. Zhang, S. et al. SipA, SopA, SopB, SopD and SopE2 act in concert to induce diarrhea in calves infected with Salmonella enterica serotype Typhimurium. Infect. Immun. 70, 3843-3855 (2002
74. Zhang, S. et al. Phage-mediated horizontal transfer of the sopE1 gene increases enteropathogenicity of Salmonella enterica serotype Typhimurium for calves. FEMS Microbiol. Lett. 217, 243-247 (2002
75. Hapfelmeier, S. et al. Role of the Salmonella pathogenicity island 1 effector proteins SipA, SopB, SopE, and SopE2 in Salmonella enterica subspecies 1 serovar Typhimurium colitis in streptomycin-pretreated mice. Infect. Immun. 72, 795-809 (2004
76. Hardt, W. D., Chen, L. M., Schuebel, K. E., Bustelo, X. R. & Galan, J. E. S. typhimurium encodes an activator of Rho GTPases that induces membrane ruffling and nuclear responses in host cells. Cell 93, 815-826 (1998
77. Figueiredo, J. F. et al. Salmonella enterica Typhimurium SipA induces CXC-chemokine expression through p38MAPK and JUN pathways. Microbes Infect. 11, 302-310 (2009
78. Keestra, A. M. et al. A Salmonella virulence factor activates the NOD1/NOD2 signaling pathway. mBio 2, e00266 11 (2011
79. Keestra, A. M. & Bäumler, A. J. Detection of enteric pathogens by the nodosome. Trends Immunol. 35, 123-130 (2014
80. Keestra, A. M. et al. Manipulation of small Rho GTPases is a pathogen-induced process detected by NOD1. Nature 496, 233-237 (2013
81. Yoo, N. J. et al. Nod1, a CARD protein, enhances pro-interleukin 1β processing through the interaction with pro-caspase 1. Biochem. Biophys. Res. Commun. 299, 652-658 (2002
82. Nasrallah, S. M. & Nassar, V. H. Enteric fever: a clinicopathologic study of 104 cases. Am. J. Gastroenterol. 69, 63-69 (1978
83. Raffatellu, M., Wilson, R. P., Winter, S. E. & Bdumler, A. J. Clinical pathogenesis of typhoid fever. J. Infect. Dev. Ctries 2, 260-266 (2008
84. Raffatellu, M. et al. Capsule-mediated immune evasion: a new hypothesis explaining aspects of typhoid fever pathogenesis. Infect. Immun. 74, 19-27 (2006
85. Tsolis, R. M., Young, G. M., Solnick, J. V. & Bdumler, A. J. From bench to bedside: stealth of enteroinvasive pathogens. Nature Rev. Microbiol. 6, 883-892 (2008
86. Parkhill, J. et al. Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18. Nature 413, 848-852 (2001
87. Virlogeux, I., Waxin, H., Ecobichon, C. & Popoff, M. Y. Role of the viaB locus in synthesis, transport and expression of Salmonella typhi Vi antigen. Microbiology 141, 3039-3047 (1995
88. Wetter, M. et al. Molecular characterization of the viaB locus encoding the biosynthetic machinery for Vi capsule formation in Salmonella Typhi. PLoS ONE 7, e45609 (2012
89. Heyns, K. & Kiessling, G. Strukturaufklarung des Vi antigens aus Citrobacter freundii (E. coli) 5396/38. Carbohydr. Res. 3, 340-353 (in German) (1967
90. Looney, R. J. & Steigbigel, R. T. Role of the Vi antigen of Salmonella typhi in resistance to host defense in vitro. J. Lab. Clin. Med. 108, 506-516 (1986
91. Wilson, R. P. et al. The Vi capsular polysaccharide prevents complement receptor 3 mediated clearance of Salmonella enterica serotype Typhi. Infect. Immun. 79, 830-837 (2011
92. Miller, R. M., Garbus, J. & Hornick, R. B. Lack of enhanced oxygen consumption by polymorphonuclear leukocytes on phagocytosis of virulent Salmonella typhi. Science 175, 1010-1011 (1972
93. Mollnes, T. E. et al. Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 100, 1869-1877 (2002
94. Wilson, R. P. et al. The Vi capsule prevents Toll-like receptor 4 recognition of Salmonella. Cell. Microbiol. 10, 876-890 (2008
95. Raffatellu, M. et al. The Vi capsular antigen of Salmonella enterica serotype Typhi reduces Toll-like receptor-dependent interleukin 8 expression in the intestinal mucosa. Infect. Immun. 73, 3367-3374 (2005
96. Hirose, K. et al. Survival of Vi capsulated and Vi deleted Salmonella typhi strains in cultured macrophage expressing different levels of CD14 antigen. FEMS Microbiol. Lett. 147, 259-265 (1997
97. Jansen, A. M. et al. A Salmonella Typhimurium-Typhi genomic chimera: a model to study Vi polysaccharide capsule function in vivo. PLoS Pathog. 7, e1002131 (2011
98. Noriega, L. M., Van der Auwera, P., Daneau, D., Meunier, F. & Aoun, M. Salmonella infections in a cancer center. Support. Care Cancer 2, 116-122 (1994
99. Tumbarello, M., Tacconelli, E., Caponera, S., Cauda, R. & Ortona, L. The impact of bacteraemia on HIV infection. Nine years experience in a large Italian university hospital. J. Infect. 31, 123-131 (1995
100. Cunnington, A. J. et al. Prolonged neutrophil dysfunction after Plasmodium falciparum malaria is related to hemolysis and heme oxygenase 1 induction. J. Immunol. 189, 5336-5346 (2012
101. Janis, C. et al. In vivo regulation of the Vi antigen in Salmonella and induction of immune responses with an in vivo-inducible promoter. Infect. Immun. 79, 2481-2488 (2011
102. Chitkara, Y. K. & Urquhart, A. E. Fluorescent Vi antibody test in the screening of typhoid carriers. Am. J. Clin. Pathol. 72, 87-89 (1979
103. Nolan, C. M. et al. Evaluation of a new assay for Vi antibody in chronic carriers of Salmonella typhi. J. Clin. Microbiol. 12, 22-26 (1980
104. Losonsky, G. A. et al. Development and evaluation of an enzyme-linked immunosorbent assay for serum Vi antibodies for detection of chronic Salmonella typhi carriers. J. Clin. Microbiol. 25, 2266-2269 (1987
105. Crawford, R. W. et al. Loss of very-long O antigen chains optimizes capsule-mediated immune evasion by Salmonella enterica serovar Typhi. mBio 4, e00232 13 (2013
106. Bravo, D. et al. Growth-phase regulation of lipopolysaccharide O antigen chain length influences serum resistance in serovars of Salmonella. J. Med. Microbiol. 57, 938-946 (2008
107. Haneda, T. et al. The capsule-encoding viaB locus reduces intestinal inflammation by a Salmonella pathogenicity island 1 independent mechanism. Infect. Immun. 77, 2932-2942 (2009
108. Winter, S. E. et al. The TviA auxiliary protein renders the Salmonella enterica serotype Typhi RcsB regulon responsive to changes in osmolarity. Mol. Microbiol. 74, 175-193 (2009
109. Winter, S. E. et al. A rapid change in virulence gene expression during the transition from the intestinal lumen into tissue promotes systemic dissemination of Salmonella. PLoS Pathog. 6, e1001060 (2010
110. Tran, Q. T. et al. The Salmonella enterica serotype Typhi Vi capsular antigen is expressed after the bacterium enters the ileal mucosa. Infect. Immun. 78, 527-535 (2010
111. Winter, S. E., Raffatellu, M., Wilson, R. P., Russmann, H. & Bäumler, A. J. The Salmonella enterica serotype Typhi regulator TviA reduces interleukin 8 production in intestinal epithelial cells by repressing flagellin secretion. Cell. Microbiol. 10, 247-261 (2008
112. Atif, S. M., Winter, S. E., Winter, M. G., McSorley, S. J. & Bäumler, A. J. Salmonella enterica serovar Typhi impairs CD4 T cell responses by reducing antigen availability. Infect. Immun. 82, 2247-2254 (2014
113. Winter, S. E. et al. Salmonella enterica serovar Typhi conceals the invasion-associated type three secretion system from the innate immune system by gene regulation. PLoS Pathog. 10, e1004207 (2014
114. Raffatellu, M. et al. The capsule encoding the viaB locus reduces interleukin 17 expression and mucosal innate responses in the bovine intestinal mucosa during infection with Salmonella enterica serotype Typhi. Infect. Immun. 75, 4342-4350 (2007
115. Olsen, S. J. et al. Outbreaks of typhoid fever in the United States, 1960-1999. Epidemiol. Infect. 130, 13-21 (2003
116. Glynn, J. R. & Palmer, S. R. Incubation period, severity of disease, and infecting dose: evidence from a Salmonella outbreak. Am. J. Epidemiol. 136, 1369-1377 (1992
117. Crump, J. A., Luby, S. P. & Mintz, E. D. The global burden of typhoid fever. Bull. World Health Organ. 82, 346-353 (2004
118. Crump, J. A., Ram, P. K., Gupta, S. K., Miller, M. A. & Mintz, E. D. Part I. Analysis of data gaps pertaining to Salmonella enterica serotype Typhi infections in low and medium human development index countries, 1984-2005. Epidemiol. Infect. 136, 436-448 (2008
119. Majowicz, S. E. et al. The global burden of nontyphoidal Salmonella gastroenteritis. Clin. Infect. Dis. 50, 882-889 (2010
120. Gilks, C. F. Acute bacterial infections and HIV disease. Br. Med. Bull. 54, 383-393 (1998
121. Watera, C. et al. 23 valent pneumococcal polysaccharide vaccine in HIV-infected Ugandan adults: 6 year follow up of a clinical trial cohort. AIDS 18, 1210-1213 (2004
122. Van Oosterhout, J. J. et al. A community-based study of the incidence of trimethoprim-sulfamethoxazole-preventable infections in Malawian adults living with HIV. J. Acquired Immune Defic. Syndr. 39, 626-631 (2005
123. Gordon, M. A. Salmonella infections in immunocompromised adults. J. Infect. 56, 413-422 (2008
124. Berkley, J. A. et al. Bacteremia among children admitted to a rural hospital in Kenya. N. Engl. J. Med. 352, 39-47 (2005
125. Enwere, G. et al. Epidemiologic and clinical characteristics of community-acquired invasive bacterial infections in children aged 2-29 months in The Gambia. Pediatr. Infect. Dis. J. 25, 700-705 (2006
126. Sigauque, B. et al. Community-acquired bacteremia among children admitted to a rural hospital in Mozambique. Pediatr. Infect. Dis. J. 28, 108-113 (2009
127. MacLennan, C. A. et al. The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children. J. Clin. Invest. 118, 1553-1562 (2008
128. OReilly, C. E. et al. Risk factors for death among children less than 5 years old hospitalized with diarrhea in rural western Kenya, 2005-2007: a cohort study. PLoS Med. 9, e1001256 (2012
129. Hsieh, M. M., Everhart, J. E., Byrd-Holt, D. D., Tisdale, J. F. & Rodgers, G. P. Prevalence of neutropenia in the U. S. population: age, sex, smoking status, and ethnic differences. Ann. Intern. Med. 146, 486-492 (2007
130. Andres, E. & Maloisel, F. Idiosyncratic drug-induced agranulocytosis or acute neutropenia. Curr. Opin. Hematol. 15, 15-21 (2008
131. Grubb, S. C., Bult, C. J. & Bogue, M. A. Mouse phenome database. Nucleic Acids Res. 42, D825-D834 (2014
132. Maddatu, T. P., Grubb, S. C., Bult, C. J. & Bogue, M. A. Mouse phenome database (MPD). Nucleic Acids Res. 40, D887-D894 (2012
133. Eisenhauer, P. B. & Lehrer, R. I. Mouse neutrophils lack defensins. Infect. Immun. 60, 3446-3447 (1992
134. Ganz, T. et al. Defensins. Natural peptide antibiotics of human neutrophils. J. Clin. Invest. 76, 1427-1435 (1985
135. Selsted, M. E., Harwig, S. S., Ganz, T., Schilling, J. W. & Lehrer, R. I. Primary structures of three human neutrophil defensins. J. Clin. Invest. 76, 1436-1439 (1985
136. Modi, W. S. & Yoshimura, T. Isolation of novel GRO genes and a phylogenetic analysis of the CXC chemokine subfamily in mammals. Mol. Biol. Evol. 16, 180-193 (1999
137. Van Den Berg, J. M. et al. Chronic granulomatous disease: the European experience. PLoS ONE 4, e5234 (2009
138. Gotze, O. & Müller-Eberhard, H. J. The C3 activator system: an alternate pathway of complement activation. J. Exp. Med. 134, 90-108 (1971
139. Law, S. K. & Levine, R. P. Interaction between the third complement protein and cell surface macromolecules. Proc. Natl Acad. Sci. USA 74, 2701-2705 (1977
140. Tack, B. F., Harrison, R. A., Janatova, J., Thomas, M. L. & Prahl, J. W. Evidence for presence of an internal thiolester bond in third component of human complement. Proc. Natl Acad. Sci. USA 77, 5764-5768 (1980
141. Densen, P., MacKeen, L. A. & Clark, R. A. Dissemination of gonococcal infection is associated with delayed stimulation of complement-dependent neutrophil chemotaxis in vitro. Infect. Immun. 38, 563-572 (1982
142. Musher, D. M., Hague-Park, M., Gyorkey, F., Anderson, D. C. & Baughn, R. E. The interaction between Treponema pallidum and human polymorphonuclear leukocytes. J. Infect. Dis. 147, 77-86 (1983
143. Podack, E. R., Kolb, W. P. & Muller-Eberhard, H. J. The C5b 9 complex: subunit composition of the classical and alternative pathway-generated complex. J. Immunol. 116, 1431-1434 (1976